View in EDS

Impact of Excluding Anti-HLA-C and -DP Antibodies From the Allocation System on Kidney Transplant Access.

Saved in:
Bibliographic Details
Title: Impact of Excluding Anti-HLA-C and -DP Antibodies From the Allocation System on Kidney Transplant Access.
Authors: Lepage M; National Blood Service (EFS), HLA Laboratory, Décines-Charpieu, France., Barba T; Department of Internal Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.; CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France., Charmetant X; CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France.; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.; Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon, France., Chauvelot L; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France., Guezennec M; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France., Goret-Roycourt K; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France., Buron F; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France., Thaunat O; CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France.; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.; Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon, France., Morelon E; CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France.; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.; Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon, France., Dubois V; National Blood Service (EFS), HLA Laboratory, Décines-Charpieu, France.; CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France., Koenig A; CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Univ. Lyon, Lyon, France.; Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.; Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon, France.
Source: HLA [HLA] 2026 Jul; Vol. 108 (1), pp. e70822.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101675570 Publication Model: Print Cited Medium: Internet ISSN: 2059-2310 (Electronic) Linking ISSN: 20592302 NLM ISO Abbreviation: HLA Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-2310
DOI:10.1111/tan.70822